Cargando…

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

Pain is a natural protective mechanism and has a warning function signaling imminent or actual tissue damage. Neuropathic pain (NP) results from a dysfunction and derangement in the transmission and signal processing along the nervous system and it is a recognized disease in itself. The prevalence o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Intiso, Domenico, Basciani, Mario, Santamato, Andrea, Intiso, Marta, Di Rienzo, Filomena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516923/ https://www.ncbi.nlm.nih.gov/pubmed/26134256 http://dx.doi.org/10.3390/toxins7072454

Ejemplares similares

High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?
por: Intiso, Domenico, et al.
Publicado: (2020)

Therapeutic Use of Botulinum Toxin in Neurorehabilitation
por: Intiso, Domenico
Publicado: (2012)

Botulinum Toxin—A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke
por: Intiso, Domenico, et al.
Publicado: (2023)

CRITICAL ILLNESS POLYNEUROPATHY AND FUNCTIONAL OUTCOME IN SUBJECTS WITH COVID-19: REPORT ON FOUR PATIENTS AND A SCOPING REVIEW OF THE LITERATURE
por: INTISO, Domenico, et al.
Publicado: (2022)

Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy
por: Intiso, Domenico, et al.
Publicado: (2020)

Ultrasonographic Evaluation of Three Approaches for Botulinum Toxin Injection into Tibialis Posterior Muscle in Chronic Stroke Patients with Equinovarus Foot: An Observational Study
por: Spina, Stefania, et al.
Publicado: (2021)

Thrombocytosis after hip and knee surgery in the rehabilitation setting: is it an occasional phenomenon? Relationship with deep venous thrombosis and functional outcome
por: Intiso, Domenico, et al.
Publicado: (2015)

Botulinum Toxin for the Treatment of Neuropathic Pain
por: Park, JungHyun, et al.
Publicado: (2017)

Case Report: Functional Outcome of COVID-19 Subjects With Myasthenia Gravis and Critical Illness Polyneuropathy
por: Intiso, Domenico, et al.
Publicado: (2022)

Botulinum Toxin for Central Neuropathic Pain
por: Park, Jihye, et al.
Publicado: (2018)

Botulinum Neurotoxins: From Toxin to Medicine
por: Santamato, Andrea
Publicado: (2023)

Recovery and long term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review
por: Intiso, Domenico, et al.
Publicado: (2022)

ICU-acquired weakness: should medical sovereignty belong to any specialist?
por: Intiso, Domenico
Publicado: (2018)

Botulinum Toxin for Neuropathic Pain: A Review of the Literature
por: Oh, Hyun-Mi, et al.
Publicado: (2015)

Botulinum toxin type A for neuropathic pain in patients with spinal cord injury
por: Han, Zee‐A, et al.
Publicado: (2016)

High Doses of Botulinum Toxin Type A for the Treatment of Post-Stroke Spasticity: Rationale for a Real Benefit for the Patients
por: Santamato, Andrea
Publicado: (2022)

Effectiveness of Botulinum Toxin in the Treatment of Neuropathic Pain: A Literature Review
por: Dekhne, Anushka, et al.
Publicado: (2023)

Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain
por: Moon, Young Eun, et al.
Publicado: (2016)

Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic
por: Bartolo, Michelangelo, et al.
Publicado: (2020)

Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020)

Impact of healthcare-associated infections on functional outcome of severe acquired brain injury during inpatient rehabilitation
por: Bartolo, Michelangelo, et al.
Publicado: (2022)

Botulinum Toxin-A for the Treatment of Neuropathic Pain after Decompressive Craniotomy in Stroke: Two Cases
por: Teuschl, Yvonne, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of Efficacy of Botulinum Toxin A for Neuropathic Pain
por: Datta Gupta, Anupam, et al.
Publicado: (2022)

Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review
por: Val, Matteo, et al.
Publicado: (2023)

Intra-articular injection of botulinum toxin type A for shoulder pain in glenohumeral osteoarthritis: a case series summary and review of the literature
por: Cinone, Nicoletta, et al.
Publicado: (2018)

Botulinum Toxin Type A—A Modulator of Spinal Neuron–Glia Interactions under Neuropathic Pain Conditions
por: Rojewska, Ewelina, et al.
Publicado: (2018)

The role of botulinum toxin type A related axon transport in neuropathic pain induced by chronic constriction injury
por: Bu, Huilian, et al.
Publicado: (2022)

Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials
por: Lippi, Lorenzo, et al.
Publicado: (2022)

Botulinum Toxin Type A Injection for Neuropathic Pain in a Patient With a Brain Tumor: A Case Report
por: Nam, Kyung Eun, et al.
Publicado: (2017)

Mechanisms of Botulinum Toxin Type A Action on Pain
por: Matak, Ivica, et al.
Publicado: (2019)

The Effect of Robotic Assisted Gait Training With Lokomat® on Balance Control After Stroke: Systematic Review and Meta-Analysis
por: Baronchelli, Federica, et al.
Publicado: (2021)

Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study
por: Picelli, Alessandro, et al.
Publicado: (2021)

Therapeutic use of botulinum toxin in pain treatment
por: Kumar, Raj
Publicado: (2018)

The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta‐analysis of randomized controlled trials
por: Wei, Jiangshan, et al.
Publicado: (2019)

Increasing the Passive Range of Joint Motion in Stroke Patients Using Botulinum Toxin: The Role of Pain Relief
por: Trompetto, Carlo, et al.
Publicado: (2023)

Application of Botulinum Toxin in Pain Management
por: Sim, Woo Seog
Publicado: (2011)

Use of botulinum toxin in musculoskeletal pain
por: Singh, Jasvinder A
Publicado: (2013)

A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury
por: Li, Gang, et al.
Publicado: (2017)

Healthcare-Associated Infections in Subjects With Severe Acquired Brain Injury: The Effect of Microbial Colonization on the Functional Outcome. Data From a Multicenter Observational Study
por: Bartolo, Michelangelo, et al.
Publicado: (2020)

Can Botulinum Toxin Type A effectively treat neuropathic pain in spinal cord injury?: A protocol of systematic review and meta-analysis
por: Wang, Zeng-mian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g1if9o24k3u9i0o6m924qkg204